Christos Evangelou
Medical Writer at Freelance
Freelance medical writer and medical communications consultant with a passion for science and health. #MedComms #SciComm #MedRight #Health #Science
Articles
-
1 day ago |
medscape.com | Christos Evangelou
Although targeted therapies and immunotherapy have improved survival outcomes in many patients with lung cancer, these therapies come at a cost, not only financially but also in terms of cumulative and long-term treatment toxicities. But could patients benefit from receiving less therapy rather than more?
-
1 week ago |
medscape.com | Christos Evangelou
The American Society of Clinical Oncology (ASCO) has released updated guidelines to guide fertility preservation for people with cancer, with the previous update published in 2018. The 2025 update reflects substantial growth in the evidence base, with 166 studies incorporated compared with just 61 studies in the 2018 guidelines.
-
3 weeks ago |
pathologynews.com | Christos Evangelou
Like what you see so far? Sign-in to continue reading with unlimited access to all content and features. It only takes a few seconds to sign-up and it is completely free!Already registered? Click here to login.
-
1 month ago |
pathologynews.com | Christos Evangelou
Like what you see so far? Sign-in to continue reading with unlimited access to all content and features. It only takes a few seconds to sign-up and it is completely free!Already registered? Click here to login.
-
1 month ago |
crisprmedicinenews.com | Christos Evangelou
Scientists at East China Normal University and YolTech Therapeutics in Shanghai developed a new treatment approach for primary hyperoxaluria type 1 (PH1), a rare but severe genetic disorder that can lead to kidney failure in young children.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 381
- Tweets
- 884
- DMs Open
- Yes